A large pooled analysis refines gene expression-based molecular subclasses in cutaneous melanoma.

Area of Science:

• Oncology
• Genomics
• Molecular Biology

Background:

• Cutaneous melanoma exhibits significant molecular heterogeneity.
• Understanding gene expression patterns is crucial for melanoma classification and treatment.
• Previous classifications have not fully captured the molecular diversity of melanoma.

Purpose of the Study:

• To define and characterize expression-based molecular subclasses of cutaneous melanoma.
• To identify the dominant biological pathways associated with each subclass.
• To evaluate the clinical relevance and prognostic value of these subclasses.

Main Methods:

• Consensus clustering was applied to two independent cutaneous melanoma expression datasets (n=405, n=473).
• Gene set enrichment analysis identified dominant biological pathways for each subclass.
• Multivariate survival analysis and anti-PD-1 therapy response rates were used for clinical evaluation.

Main Results:

• Four distinct molecular subclasses were identified: 'Oxidative phosphorylation', 'Oestrogen response/p53-pathway', 'Immune', and 'Cell cycle'.
• The 'Oxidative phosphorylation' subclass showed significantly shorter overall survival.
• A trend towards differential response rates to anti-PD-1 therapy was observed, with the 'Immune' subclass showing higher response rates.

Conclusions:

• Cutaneous melanoma can be stratified into four distinct molecular subclasses based on gene expression.
• These subclasses have different dominant biological pathways and clinical implications.
• This molecular stratification may aid in personalized treatment strategies for melanoma.